CINCA Syndrome
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease (NCT00770601) | Novartis Pharmaceuticals | 2009-01-26 |
Track CINCA Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.